Taiwan FDA warns against honey drink found to contain methoxsalen
Taipei, Nov. 12 (CNA) Taiwan's Food and Drug Administration (FDA) said Friday that buyers of Atomy Corp.'s HemoHIM honey drink should stop using it after it was found to contain methoxsalen, a medication that potentially causes liver damage.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
First German parliamentary group since COVID-19 arrives in Taiwan10/02/2022 11:48 AM
Hot, dry weather forecast for Sunday as autumn heatwave continues10/02/2022 10:48 AM
Taiwan headline news10/02/2022 10:15 AM
Taiwanese player wins South Korean go-kart racing title10/01/2022 09:51 PM
Taichung Commercial Bank board agrees to acquire American bank10/01/2022 09:49 PM